26 August 2025
26 August 2025
Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates.
Bretisilocin, a 5-HT2A receptor agonist and 5-HT releaser, has been designed to reduce the duration of psychoactive experience.
As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of alternative methods will “take time”.
Bavarian Nordic reported a strong H1 2025 as the company prepares to receive an offer letter.
Tariff rates on generic pharmaceutical products imported from the EU will now be “effectively zero or close to zero”.
Datroway's approval is based on results from the Phase III TROPION-Breast01 trial.
The updated Covid-19 vaccine is approved for individuals six months and older.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
